William S John1, He Zhu2, Paolo Mannelli2, Geetha A Subramaniam3, Robert P Schwartz4, Jennifer McNeely5, Li-Tzy Wu6. 1. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA. Electronic address: william.john@duke.edu. 2. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA. 3. National Institute on Drug Abuse, Bethesda, MD, USA. 4. Friends Research Institute, Inc., Baltimore, MD, USA. 5. Department of Population Health, New York University School of Medicine, New York, NY, USA. 6. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; Department of Medicine, Division of General Internal Medicine, Duke University Medical Center, Durham, NC, USA; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA; Center for Child and Family Policy, Sanford School of Public Policy, Duke University, Durham, NC, USA. Electronic address: litzy.wu@duke.edu.
Abstract
BACKGROUND: Current data suggest that opioid misuse or opioid use disorder (OUD) may be over represented among tobacco users. However, this association remains understudied in primary care settings. A better understanding of the extent of heterogeneity in opioid misuse among primary care patients who use tobacco may have implications for improved primary care-based screening, prevention, and intervention approaches. METHODS: Data were derived from a sample of 2000 adult (aged ≥18) primary care patients across 5 distinct clinics. Among past-year tobacco users (n = 882), we assessed the prevalence of opioid misuse and OUD by sociodemographic characteristics and past-year polysubstance use. Latent class analysis (LCA) was used to identify heterogeneous subgroups of tobacco users according to past-year polysubstance use patterns. Multinomial logistic regression was used to examine variables associated with LCA-defined class membership. RESULTS: Past-year tobacco use was reported by >84% of participants who reported past-year opioid misuse or OUD. Among those reporting past-year tobacco use, the prevalence of past-year opioid misuse and OUD was 14.0% and 9.5%, respectively. The prevalence of opioid misuse or OUD was highest among tobacco users who were male or unemployed. Three LCA-defined classes among tobacco users were identified including a tobacco-minimal drug use group (78.0%), a tobacco-cannabis use group (10.1%), and a tobacco-opioid/polydrug use group (11.9%). Class membership differed by sociodemographic characteristics. CONCLUSIONS: Results from this study support the benefit of more comprehensive assessment of and/or monitoring for opioid misuse among primary care patients who use tobacco, particularly for those who are male, unemployed, or polydrug users.
BACKGROUND: Current data suggest that opioid misuse or opioid use disorder (OUD) may be over represented among tobacco users. However, this association remains understudied in primary care settings. A better understanding of the extent of heterogeneity in opioid misuse among primary care patients who use tobacco may have implications for improved primary care-based screening, prevention, and intervention approaches. METHODS: Data were derived from a sample of 2000 adult (aged ≥18) primary care patients across 5 distinct clinics. Among past-year tobacco users (n = 882), we assessed the prevalence of opioid misuse and OUD by sociodemographic characteristics and past-year polysubstance use. Latent class analysis (LCA) was used to identify heterogeneous subgroups of tobacco users according to past-year polysubstance use patterns. Multinomial logistic regression was used to examine variables associated with LCA-defined class membership. RESULTS: Past-year tobacco use was reported by >84% of participants who reported past-year opioid misuse or OUD. Among those reporting past-year tobacco use, the prevalence of past-year opioid misuse and OUD was 14.0% and 9.5%, respectively. The prevalence of opioid misuse or OUD was highest among tobacco users who were male or unemployed. Three LCA-defined classes among tobacco users were identified including a tobacco-minimal drug use group (78.0%), a tobacco-cannabis use group (10.1%), and a tobacco-opioid/polydrug use group (11.9%). Class membership differed by sociodemographic characteristics. CONCLUSIONS: Results from this study support the benefit of more comprehensive assessment of and/or monitoring for opioid misuse among primary care patients who use tobacco, particularly for those who are male, unemployed, or polydrug users.
Authors: Lisa R LaRowe; Lauren N Chilcott; Michael J Zvolensky; Peter A Vanable; Kelley Flood; Joseph W Ditre Journal: Subst Use Misuse Date: 2018-04-30 Impact factor: 2.164
Authors: Li-Tzy Wu; Jennifer McNeely; Geetha A Subramaniam; Kathleen T Brady; Gaurav Sharma; Paul VanVeldhuisen; He Zhu; Robert P Schwartz Journal: Drug Alcohol Depend Date: 2017-07-13 Impact factor: 4.492
Authors: Li-Tzy Wu; Walter Ling; Bruce Burchett; Dan G Blazer; Chongming Yang; Jeng-Jong Pan; Bryce B Reeve; George E Woody Journal: Drug Alcohol Depend Date: 2011-04-17 Impact factor: 4.492
Authors: Danielle E Ramo; Kevin L Delucchi; Sharon M Hall; Howard Liu; Judith J Prochaska Journal: J Stud Alcohol Drugs Date: 2013-03 Impact factor: 2.582
Authors: Sharon M Hall; Gary L Humfleet; James J Gasper; Kevin L Delucchi; David F Hersh; Joseph R Guydish Journal: Nicotine Tob Res Date: 2018-04-02 Impact factor: 4.244
Authors: Jennifer McNeely; Li-Tzy Wu; Geetha Subramaniam; Gaurav Sharma; Lauretta A Cathers; Dace Svikis; Luke Sleiter; Linnea Russell; Courtney Nordeck; Anjalee Sharma; Kevin E O'Grady; Leah B Bouk; Carol Cushing; Jacqueline King; Aimee Wahle; Robert P Schwartz Journal: Ann Intern Med Date: 2016-09-06 Impact factor: 25.391
Authors: R Kathryn McHugh; Amy C Janes; Margaret L Griffin; Nadine Taghian; Shelly F Greenfield; Roger D Weiss Journal: Subst Use Misuse Date: 2020-02-10 Impact factor: 2.164
Authors: Nicole M Wagner; Ingrid A Binswanger; Susan M Shetterly; Deborah J Rinehart; Kris F Wain; Christian Hopfer; Jason M Glanz Journal: Drug Alcohol Depend Date: 2021-08-28 Impact factor: 4.852
Authors: Lisa A Marsch; Aimee Campbell; Cynthia Campbell; Ching-Hua Chen; Emre Ertin; Udi Ghitza; Chantal Lambert-Harris; Saeed Hassanpour; August F Holtyn; Yih-Ing Hser; Petra Jacobs; Jeffrey D Klausner; Shea Lemley; David Kotz; Andrea Meier; Bethany McLeman; Jennifer McNeely; Varun Mishra; Larissa Mooney; Edward Nunes; Chrysovalantis Stafylis; Catherine Stanger; Elizabeth Saunders; Geetha Subramaniam; Sean Young Journal: J Subst Abuse Treat Date: 2020-03
Authors: Francisco A Montiel Ishino; Philip R McNab; Tamika Gilreath; Bonita Salmeron; Faustine Williams Journal: BMC Public Health Date: 2020-11-18 Impact factor: 3.295